Clinical trial
Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had Prior Prophylaxis
NCT02646566 is registered in ClinicalTrials.gov with Acacia Pharma Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had Prior Prophylaxis
- Lead sponsor
- Acacia Pharma Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- January 31, 2017
- Enrollment
- 705 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.